Revitalizing the shareholding of biochemical equity
On December 17th, a notice showed that Zhemin Tianhong and Kaisa had a new drama in the fight for revitalization of biochemistry. The announcement showed that the two directors and an independent director of the revitalization of the biochemical two shareholders, Jiazhaoye, voted against the seven proposals put forward by the board of directors. The helpless major shareholder Zhemin Tianhong has two seats in the seven seats on the board of directors, plus two other independent directors choose to support Zhemin Tianhong. 4. In the end, all the schemes were approved with 4 votes in favor and 3 votes against. The Cailian News Agency found that six of the seven proposals were aimed at revitalizing biochemical core company Guangdong Shuanglin Bio-Pharmaceutical Co., Ltd. (hereinafter referred to as “Shuanglin Biologyâ€). Fight for core assets Shuanglin Bio is the most important asset for revitalizing biochemistry, mainly engaged in research and development, production and sales of blood products. The 2017 annual report shows that the company's operating income for the year was 685 million yuan, and net profit was 116 million yuan, accounting for more than 95% of Zhenxing's total biochemical revenue. The fuse for this competition is a personnel appointment and dismissal of Shuanglin. On December 14, 2018, Shuanglin Biological's board of directors removed the current general manager Zhu Guangzu. Just around 8 pm that day, Zhenxing Biochemical Chairman Chen Hao convened an emergency board of directors and proposed seven proposals, asking the board members to vote. Of the seven proposals, six are related to Shuanglin Bio, including the “Removal of Shi Yuewu, Zheng Yi, Luo Jun, Yan Xiaoping, Zhang Guangdong Shuanglin Biological Directors†and “On the appointment of Yang Cheng to become Shuanglin Proposal of Executive Directors and Legal Representatives, etc. In this regard, on behalf of Kaisa's two directors Luo Jun, Zheng Yi and independent director Liu Shujin voted against. The directors of Jiazhaoye believe that the above six proposals are not within the scope of the board of directors of the listed company, and the dismissal of general manager Zhu Guangzu is also a matter for the board of Shuanglin Biological. At about 8 o'clock in the evening, I suddenly convened the board of directors and submitted seven proposals. The board of directors was convened when the members of the board of directors were not present. The proposal materials were about 10,000 words. The directors were required to vote at 8:30 pm on the same day. As the moderator, Chang did not elaborate on the relevant proposals to other directors. These are obviously contrary to the requirements of the exchanges for all directors. Despite this, all the bills were finally passed in a 4:3 ratio. Yang Cheng, who was involved in the above proposal, became the company's chief financial officer. He served as the managing director of Zhemin Investment, the general manager of the finance department, and the head of risk control and post-investment. Both sides have repeatedly resorted The latest shareholding structure of Revitalization Biochemical showed that Zhemin Tiantian held 27.49% of its shares, and its concerted action Zhemin invested 2.40%, a total of 29.89%, only one step away from the tender offer. The second shareholder Zhenxing Group holds 22.61%. Previously, Kaisa had acquired a 18.57% stake in Zhenxing Biochemical through a wholly-owned shipping health plan of 2.187 billion yuan. At the same time, Zhenxing Biochemical's major shareholder Zhenxing Group intends to transfer 11 million shares to China Cinda Shenzhen Branch, accounting for 4.04% of the total share capital. According to the agreement signed by the three parties, the shipping health will be entrusted by the voting rights of Zhenxing Group and China Xinda Shenzhen Branch. As a result, the proportion of ST biochemical voting rights is 22.61%. Informed sources revealed to the reporters of the Financial Association that Jiazhao had long been in contact with the major shareholders of Zhenxing Group before Zhejiang Investment was involved in the revitalization of biochemicals, and Kaisa had already arranged for Shuanglin. Unexpectedly, Zhejiang people voted to kill in the middle, and the dispute over equity was born. In the middle, the revitalization group filed a lawsuit with the court to determine that Zhemin Tiantianhong seriously violated the relevant provisions of the “Administrative Measures on the Acquisition of Listed Companies†and the “Securities Lawâ€, and revitalized the major shareholders of biochemical originals to report to the CBRC. Tianhong related enterprises handled 1.4 billion yuan of cross-border financing for internal security, which was used to acquire the equity of listed companies. Kaisa previously said that the company's acquisition of revitalization biochemical is mainly considered to be the rigid demand for blood products market, and long-term supply is in short supply; the blood products industry is a semi-monopoly industry, and the listed companies are particularly scarce. Kaisa is vigorously developing the health industry, and the blood products industry can serve as an entry point for the company to enter the field of biological products. Zhejiang People's Investment Tianhong Xiangzhong Revitalization Biochemistry is optimistic about the development prospects of the blood products industry and the development potential of listed companies. It will use its own resource advantages to help listed companies improve management efficiency, promote the stable development of listed companies, and enhance the listed companies. Profitability and risk resistance. Now the two sides are not giving each other, what are the tricks behind? The Cailian News Agency interviewed Zhemin Tiantian unsuccessful, and turned to contact Kaisa, the other party said that the company's related parties are opening the board of directors. As of press time, the other party has not received a reply. Urine analyzer is an automated instrument for determining certain chemical components in urine. It is an important tool for automated urine inspection in medical laboratories. This instrument has the advantages of simple and fast operation. However, improper use of urine analyzers and many intermediate links and influencing factors directly affect the accuracy of automated analysis results, which will not only cause errors in experimental results, but even delay diagnosis. Therefore, operators are required to understand the principles, performance and precautions of automated instruments. And the knowledge of influencing factors and other aspects are fully understood, and the correct use of automated instruments can make the results obtained by the urine analyzer more reliable and accurate. Medical Urine Analyzer,Semi Automatic Urine Analyzer,Urine Analyzer and Strips,Accurate Urine Analyzer Jilin Sinoscience Technology Co. LTD , https://www.jilinsinoscience.com
application
In the 1950s, a single dry chemical test strip method was used to measure protein and glucose in urine, and the changes in the color of the test strip were observed with the naked eye and compared with the standard plate to obtain the corresponding values. In the 1980s, due to the high development and widespread use of computer technology, automated urine analyzers also developed rapidly, gradually developing from semi-automatic to fully-automated. Urine analyzers are often divided into two categories according to the test items: â‘ 8-11 screening combined urine test strips mainly used for newly diagnosed patients and health examinations. The eight test items included protein, glucose, PH, ketone bodies, bilirubin, urobilinogen, red blood cells (occult blood) and nitrite; in addition to the above eight tests, urine leukocyte test was added to the nine test items. On the basis of 9 of the 10 urine analyzer testing items, the urine specific density test was added. 11 testing items have added vitamin C testing. â‘¡It is mainly used for the observation of the curative effect of the diagnosed diseases, such as the combination test strip of PH, protein and occult blood (red blood cells) for kidney disease; the combination test strip of PH, sugar and ketone body for diabetes; the combination of bilirubin and urobilinogen for liver disease test tape.
principle
This type of instrument is generally controlled by a microcomputer, and the color change on the test strip is measured semi-quantitatively by using a spherical integrator to receive dual-wavelength reflected light. There are several reagent pads containing various reagents on the reagent strip, each of which reacts independently with the corresponding components in the urine, and displays different colors. The depth of the color is proportional to a certain component in the urine, and there is another in the reagent strip" Compensation pad", as the urine background color, compensates for the errors caused by colored urine and instrument changes.
Put the reagent strip with urine adsorbed in the colorimetric tank of the instrument, and the various reagent pads that have produced chemical reactions on the reagent strip are illuminated by the light source, and the reflected light is received by the spherical analyzer, and the photocell of the spherical analyzer is reflected. Irradiate with dual-wavelength light (measurement light passing through the filter and a reference light), and the selection of each wavelength is determined by the detection item.
The instrument automatically calculates the reflectance according to the following formula, and then compares it with the standard curve, and automatically finds and prints the corresponding results of various components. If the content of a certain component in the urine is high, the reflected light of the corresponding reagent pad is dark, otherwise it is strong.
Reflectance fraction: R(%)=Tm.Cs/TsCm×100%
In the formula, R(%) is the reflectivity; Tm is the reflection intensity of the reagent pad to the measurement wavelength; Ts is the reflection intensity of the reagent pad to the reference wavelength; Cm is the reflection intensity of the calibration pad to the measurement defect length; Cs is the calibration pair. Reflection intensity at the reference wavelength.